Microbiota-derived metabolites in colorectal cancer patients in preoperative period
K. Kaźmierczak-Siedlecka, K. Skonieczna-Żydecka, J. Palma, B.K. Sobocki, M. Świerblewski, K. Siedlecka-Kroplewska, L. Kalinowski, K. Połom Department of Medical Laboratory Diagnostics, Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland. karzyd@pum.edu.pl
OBJECTIVE: Short-chain fatty acids (SCFAs) are microbial derived metabolites, which have multiple beneficial properties. The amount of SCFAs depends on several factors, such as age, diet (mainly intake of dietary fiber), and overall health condition. The normal proportion between SCFAs is 3:1:1 for acetate, proprionate and butyrate, respectively. In colorectal cancer (CRC) patients, microbiota alterations have been shown. Consequently, metabolome within the gut might change to a large extent. Therefore, the aim of this study was to analyse the content of SCFAs and the proportion between SCFAs in the stool obtained from CRC patients in preoperative period.
PATIENTS AND METHODS: This study included 15 patients with CRC in preoperative period. The stool samples were taken and stored at -80°C in the Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Poland. The analysis of SCFAs from stool samples was conducted by means of gas chromatography.
RESULTS: This study included mainly males (66.67%, n=10). In all patients, there was abnormal proportion between SCFAs. The extremely higher concentration of butyrate was noted in 2 samples (13.33%) compared to the rest of patients. However, based on normal proportion between SCFAs, the results <1 for butyrate were noted in 93.33% of patients.
CONCLUSIONS: SCFAs pool is altered in CRC patients, among others characterized by low level of butyrate. It should be considered to administer butyrate supplementation to CRC patients especially prior to surgery to support an appropriate preparation to this treatment.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
K. Kaźmierczak-Siedlecka, K. Skonieczna-Żydecka, J. Palma, B.K. Sobocki, M. Świerblewski, K. Siedlecka-Kroplewska, L. Kalinowski, K. Połom
Microbiota-derived metabolites in colorectal cancer patients in preoperative period
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 4
Pages: 1443-1449
DOI: 10.26355/eurrev_202302_31384